Efficacy and Safety of ANTI-TNF ALPHA in BEHCET Disease: A International Multicenter Registry of 122 Patients.

被引:0
|
作者
Vallet, Helene [1 ]
Riviere, Sophie [2 ]
Deroux, Alban [3 ]
Moulis, Guillaume [4 ]
Addimanda, Olga [5 ]
Salvarani, Carlo [6 ]
Lambert, Marc [7 ]
Bielfeld, Philip [8 ]
Seve, Pascal [9 ]
Sibilia, Jean [10 ]
Fraison, Jean Baptiste [11 ]
Schoindre, Yoland [12 ]
Marie, Isabelle [13 ]
Perard, Laurent [14 ]
Papo, Thomas [15 ]
Sene, Damien [16 ]
Leroux, Gaelle [1 ]
Royant, Valerie
Perlat, Antoinette [17 ]
Mariette, Xavier [18 ]
Lidove, Olivier [19 ]
Fain, Olivier [20 ]
De Moreuil, Claire [21 ]
Blaison, Gilles [22 ]
Phuc LE Hoang [23 ]
Hachulla, Eric [24 ]
Wechsler, Bertrand
Bodaghi, Barham [25 ]
Cacoub, Patrice [26 ]
Saadoun, David [1 ]
机构
[1] Pitie Hosp, DHU Internal Med Referal Ctr Autoimmune Dis 2iB, Paris, France
[2] Lapeyronie, Montpellier, France
[3] CHU Grenoble, F-38043 Grenoble, France
[4] Dept Internal Med, Toulouse, France
[5] IRCCS, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
[6] Arcispedale S Maria Nuova, Reggio Emilia, Italy
[7] CHRU Lille, F-59037 Lille, France
[8] CHU Dijon, Dijon, France
[9] CHU Lyon, Lyon, France
[10] Univ Hosp Strasbourg, Strasbourg, France
[11] Hop Jean Verdier, Bondy, France
[12] DHU 2iB Internal Med Referal Ctr Autoimmune Dis P, Paris, France
[13] CHU Rouen, Rouen, France
[14] Hosp Civils Lyon, Lyon, France
[15] Hop Bichat Claude Bernard, F-75877 Paris, France
[16] Hop Lariboisiere, Serv Med Interne, F-75475 Paris, France
[17] CHU Rennes, Rennes, France
[18] Univ Paris 11, Le Kremlin Bicetre, France
[19] Hop Croix St Simon, Paris, France
[20] Hop St Antoine, DHU i2B, Serv Med Interne, F-75571 Paris, France
[21] CHU Brest, F-29285 Brest, France
[22] CHR, Colmar, France
[23] Hop La Pitie Salpetriere, AP HP, Paris, France
[24] Natl Scleroderma Ctr, Lille, France
[25] Hop La Pitie Salpetriere, Paris, France
[26] Grp Hosp Pitie Salpetriere, Serv Med Interne, DHU i2B, F-75634 Paris, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2757
引用
收藏
页码:S1204 / S1205
页数:2
相关论文
共 50 条
  • [21] Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease An Observational Study
    Desbois, Anne Claire
    Addimanda, Olga
    Bertrand, Anne
    Deroux, Alban
    Perard, Laurent
    Depaz, Raphael
    Hachulla, Eric
    Lambert, Marc
    Launay, David
    Subran, Benjamin
    Ackerman, Felix
    Mariette, Xavier
    Cohen, Fleur
    Marie, Isabelle
    Salvarini, Carlo
    Cacoub, Patrice
    Saadoun, David
    MEDICINE, 2016, 95 (23)
  • [22] Safety of anti-TNF alpha biological drugs
    Trotta, F.
    Valentini, G.
    REUMATISMO, 2005, 57 (04) : 34 - 39
  • [23] Ustekinumab efficacy and safety in Crohn's disease patients refractory to conventional and anti-TNF therapy: a multicenter retrospective experience.
    Wils, P.
    Bouhnik, Y.
    Flourie, B.
    Brixi, H.
    Cosnes, J.
    Allez, M.
    Duclos, B.
    Michetti, P.
    Grimaud, J. -C.
    Bommelaer, G.
    Amiot, A.
    Fumery, M.
    Filippi, J.
    Abitbol, V.
    Coffin, B.
    Simon, M.
    Laharie, D.
    Pariente, B.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S37 - S39
  • [24] Sequential Change of Endoscopic Findings and Therapeutic Efficacy of Anti-TNFα Therapy for Patients With Intestinal BehcET's Disease
    Hirayama, Yutaka
    Watanabe, Osamu
    Nakamura, Masanao
    Yamamura, Takeshi
    Goto, Hidemi
    GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) : AB368 - AB368
  • [25] Safety, efficacy, and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti-TNF
    Ben-Horin, S.
    Ungar, B.
    Kopylov, U.
    Lahat, A.
    Yavzori, M.
    Fudim, E.
    Picard, O.
    Peled, Y.
    Eliakim, R.
    Del Tedesco, E.
    Paul, S.
    Roblin, X.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S493 - S493
  • [26] Efficacy and safety of anti-TNF agents in patients with enthesitis related arthritis
    P Tynjälä
    V Honkanen
    K Aalto
    T Levälampi
    Pediatric Rheumatology, 6 (Suppl 1)
  • [27] SAFETY, EFFICACY AND PHARMACOKINETICS OF VEDOLIZUMAB IN PATIENTS WITH SIMULTANEOUS EXPOSURE TO AN ANTI-TNF
    Ben-Horin, Shomron
    Ungar, Bella
    Kopylov, Uri
    Lahat, Adi
    Yavzori, Miri
    Fudim, Ella
    Picard, Orit
    Eliakim, Abraham R.
    Del Tedesco, Emilie
    Paul, Stephane
    Roblin, Xavier
    GASTROENTEROLOGY, 2018, 154 (06) : S839 - S840
  • [28] IL-6 blockade for Behcet's disease: review on 31 anti-TNF naive and 45 anti-TNF experienced patients
    Arida, A.
    Saadoun, D.
    Sfikakis, P. P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (08) : 1575 - 1583
  • [29] Anti-TNF Agents for Behcet's Disease: Analysis of Published Data on 369 Patients
    Arida, Aikaterini
    Fragiadaki, Kalliopi
    Giavri, Eirini
    Sfikakis, Petros P.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (01) : 61 - 70
  • [30] Anti-TNFα agents are effective therapies in patients suffering from Behcet's Disease
    Castellucci, C.
    Griss, J.
    Kinaciyan, T.
    Stingl, G.
    Jalili, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S31 - S31